KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Total Non-Current Liabilities (2016 - 2025)

CareDx's Total Non-Current Liabilities history spans 13 years, with the latest figure at $110.0 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 1.79% year-over-year to $110.0 million; the TTM value through Dec 2025 reached $110.0 million, down 1.79%, while the annual FY2025 figure was $110.0 million, 1.79% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $110.0 million at CareDx, down from $116.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $203.0 million in Q4 2023 and bottomed at $69.3 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $106.8 million (2023), against an average of $106.8 million.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 81.56% in 2023 before it plummeted 44.85% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $100.6 million in 2021, then rose by 11.16% to $111.8 million in 2022, then skyrocketed by 81.56% to $203.0 million in 2023, then plummeted by 44.85% to $112.0 million in 2024, then fell by 1.79% to $110.0 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Total Non-Current Liabilities are $110.0 million (Q4 2025), $116.3 million (Q2 2025), and $110.1 million (Q1 2025).